NCT00406250View on ClinicalTrials.gov

Intravitreal Bevacizumab in Agioid Streaks

PHASE1CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

December 31, 2008

Study Completion Date

May 31, 2009

Conditions
Angioid StreaksChoroidal Neovascularization
Interventions
DRUG

intravitreal injection

1.25 mg in 0.05 cc of bevacizumab

DRUG

intravitreal injection

1.25 mg of bevacizumab intravitreally injected in a steril field

Trial Locations (1)

80100

Dipartimento di Oftalmologia, SUN, Napoli

All Listed Sponsors
lead

University of Campania Luigi Vanvitelli

OTHER

NCT00406250 - Intravitreal Bevacizumab in Agioid Streaks | Biotech Hunter | Biotech Hunter